Mononucleosis also known as mono or kissing disease is an infectious illness caused by Epstein-Barr virus. This virus is generally spread through saliva hence, commonly called as kissing disease. It can also be spread through other ways such as sharing drinks or utensils.
Epstein-Barr virus also known as human herpesvirus 4 is the causative agent of mono/ kissing disease. Epstein–Barr virus is the most common type of virus in humans and is one of eight known human herpes virus types in the herpes family. According to the data published by Fred Hutchinson Cancer Research Center in 2018, Epstein–Barr virus infects about 9 out of 10 people globally at some point in their lives
According to study published by Fred Hutchinson Cancer Research Center in 2018, Epstein - Barr virus is the first virus, which can cause cancer in humans. According to same source, Sun Yat-Sen University Cancer Center in China estimated around 5,000 cases of nasopharyngeal carcinoma in a year due to Epstein - Barr virus.
Diagnosis of Epstein - Barr virus is difficult as its symptoms are very similar and common as other illness. This virus can be confirmed by blood test, which detects antibodies. Currently, there is no licensed or approved vaccine available for Epstein - Barr virus. However, various research organizations and companies are focusing on research activities for the development of vaccines against Epstein-Barr virus.
Mono Vaccines (Epstein - Barr virus) Market Drivers
Increasing research and development activities by various universities and companies for development of novel Mono Vaccines or Epstein - Barr virus vaccines is expected to fuel global mono vaccines (Epstein - Barr Virus) market growth in the near future. For instance, in April 2018, Researchers from Fred Hutchinson Cancer Research Center and the University of Washington developed a human antibody in laboratory tests that blocks infection by mono Epstein-Barr virus, or EBV.
Since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Mono, Epstein - Barr virus, or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV will lead to the global mono vaccines (Epstein - Barr virus) market growth.
Furthermore, funding raised by various organizations to support the development of novel EBV vaccine is also expected to create a lucrative environment for mono vaccines (Epstein - Barr virus) market growth in the forecast period. For instance, in 2017, University of Kansas School of Engineering and School of Pharmacy received US$ 1.8 million, five-year grant form National Institutes of Health for conducting research to develop an effective vaccines for EBV.
High prevalence of Epstein - Barr virus is expected to increase demand for its vaccines and this is expected to drive the mono vaccines (Epstein - Barr virus) market growth in the near future. For instance, according to data published by National Center for Biotechnology Information in 2015, Epstein–Barr virus is the most common type of virus and globally, over 95% of adults are infected with EBV. According to the same source, it was estimated that in Africa around 50% of the children are infected before 1 year of age.
Mono Vaccines (Epstein - Barr virus) Market Regional Analysis
North America is expected to hold a dominant position in global mono vaccines (Epstein - Barr virus) market over the forecast period. This is owing to increasing research and development activities by various organizations present in the region. For instance, in 2015, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, with other partners developed a nanoparticle-based vaccine against EBV. This novel vaccine can produce powerful neutralizing antibodies in vaccinated mice and non-human primates.
Asia Pacific mono vaccines (Epstein - Barr virus) market is expected to exhibit a good growth in the near future, owing to increasing prevalence of Epstein - Barr virus in the region. For instance, according to data published by Fred Hutchinson Cancer Research Center, in 2018, Epstein - Barr virus is one of the most common virus and caused most cancer cases and cancer deaths in southern China and Southeast Asia. It caused around 10% of gastric cancers and about 100% of nasopharyngeal carcinomas in the region.
Mono Vaccines (Epstein - Barr virus) Market Key Players
Key players operating in global Mono Vaccines (Epstein - Barr virus) market include, GlaxoSmithKline Plc., Henogen SA, and others.
Mono Vaccines (Epstein - Barr virus) Market Taxonomy:
The global mono vaccines (Epstein - Barr virus) market is segmented on the basis of age group, and region
By Age Group-
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.